Comparative effectiveness of the sodium–glucose cotransporter 2 inhibitor empagliflozin versus other antihyperglycemics on risk of major adverse kidney events

Yan Xie, Benjamin Bowe, Andrew K. Gibson, Janet B. McGill, Yan Yan, Geetha Maddukuri, Ziyad Al-Aly

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Comparative effectiveness of the sodium–glucose cotransporter 2 inhibitor empagliflozin versus other antihyperglycemics on risk of major adverse kidney events'. Together they form a unique fingerprint.

Medicine & Life Sciences